Drug pipeline is flush with new options for chronic constipation
Felicia Avella has suffered from irritable bowel syndrome (IBS) all her life. Over the years, she has tried numerous drugs to deal with the painful constipation that goes along with her gastrointestinal disorder, but nothing has seemed to provide relief. Then, three-and-a-half years ago, at the age of 61, Avella signed up for a clinical trial testing a new agent called linaclotide, an experimental peptide designed to increase bowel movements in people with chronic constipation. “It just changed my life,” she says. “I didn’t know what normal was until I started on the drug.” … Read more
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research